Is ticagrelor safe in intensive care unit patients? Focus on bradycardic events

Intensive Care Med. 2018 Feb;44(2):270-271. doi: 10.1007/s00134-017-5006-7. Epub 2017 Nov 30.

Authors

Xavier Valette¹, Suzanne Goursaud², Joachim Alexandre³, Maxime Leclerc², Vincent Roule⁴, Farzin Beygui⁴, Damien du Cheyron²

Affiliations

¹ Department of Medical Intensive Care, CHU de Caen, Caen, 14000, France. valette-x@chu-caen.fr.
² Department of Medical Intensive Care, CHU de Caen, Caen, 14000, France.
³ Department of Pharmacology, CHU de Caen, Caen, 14000, France.
⁴ Department of Cardiology, CHU de Caen, Caen, 14000, France.

PMID: 29189876
DOI: 10.1007/s00134-017-5006-7

No abstract available

Publication types

Letter

MeSH terms

Acute Coronary Syndrome
Adenosine
Bradycardia*
Critical Care
Humans
Intensive Care Units
Platelet Aggregation Inhibitors* / adverse effects
Ticagrelor* / adverse effects

Substances

Platelet Aggregation Inhibitors
Ticagrelor
Adenosine